Anuh Pharma Limited
BSE: ANUHPHR
Prev Close
106.2
Open Price
103.15
Volume
25,527
Today Low / High
102.3 / 104.8
52 WK Low / High
102.15 / 241.35
Range
97 - 108
The stock is currently available for trading on the Bombay Stock Exchange (BSE). Its price is 102.5, reflecting a change of -3.7 (-3.48399%). The expected target range on the BSE is 97 - 108. The stock is showing a downward trend on the BSE. This could indicate a potential risk for investors who are considering buying at this moment.
Anuh Pharma Limited Graph
Anuh Pharma Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for Anuh Pharma Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 102.50, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
| Scenario | Price | Target | Range |
|---|---|---|---|
| Bullish Scenario | 102.50 | 103.53 | 93.17 - 113.88 |
| 104.55 | 83.64 - 125.46 | ||
| 105.58 | 73.90 - 137.25 | ||
| Bearish Scenario | 102.50 | 101.48 | 91.33 - 111.62 |
| 100.45 | 80.36 - 120.54 | ||
| 99.43 | 69.60 - 129.25 |
Overview of Anuh Pharma Limited
ISIN
INE489G01022
Industry
Medical - Pharmaceuticals
Vol.Avg
13,779
Market Cap
10,796,630,400
Last Dividend
2.5
Official Website
IPO Date
2002-07-08
DCF Diff
72.43
DCF
143
Financial Ratios Every Investor Needs
Stock Dividend of ANUHPHR
| Date | Label | Adj Dividend | Dividend | Record Date | Payment Date | Declaration Date |
|---|---|---|---|---|---|---|
| 2025-08-14 | August 14, 25 | 1.5 | 1.5 | 2025-08-15 | 2025-09-21 | |
| 2024-08-16 | August 16, 24 | 2.5 | 2.5 | 2024-08-16 | 2024-09-22 | |
| 2023-08-11 | August 11, 23 | 2 | 2 | 2023-08-11 | 2023-09-17 | |
| 2022-08-03 | August 03, 22 | 1.75 | 1.75 | 2022-08-04 | 2022-09-04 | |
| 2021-08-17 | August 17, 21 | 1.5 | 1.5 | 2021-08-18 | 2021-09-18 |
Annual Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 661.51 Cr | 499.37 Cr | 162.15 Cr | 0.2451 | 0.00 Cr | 0.00 Cr | 52.17 Cr | 47.35 Cr | 9.45 | 70.36 Cr | 0.0716 |
| 2024-03-31 | 647.00 Cr | 486.66 Cr | 160.34 Cr | 0.2478 | 0.00 Cr | 1.96 Cr | 68.22 Cr | 60.06 Cr | 11.98 | 87.85 Cr | 0.0928 |
| 2023-03-31 | 527.49 Cr | 401.48 Cr | 126.00 Cr | 0.2389 | 0.00 Cr | 1.47 Cr | 45.04 Cr | 36.18 Cr | 7.22 | 57.92 Cr | 0.0686 |
| 2022-03-31 | 486.65 Cr | 377.68 Cr | 108.97 Cr | 0.2239 | 0.00 Cr | 1.33 Cr | 37.76 Cr | 30.56 Cr | 6.10 | 52.66 Cr | 0.0628 |
| 2021-03-31 | 431.96 Cr | 329.80 Cr | 102.16 Cr | 0.2365 | 0.00 Cr | 1.38 Cr | 30.98 Cr | 28.44 Cr | 5.67 | 55.66 Cr | 0.0658 |
Annual Financials Balance Sheet
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 19.56 Cr | 506.63 Cr | 180.60 Cr | 326.0248 Cr | 10.89 Cr | -8.67 Cr | 74.48 Cr | 58.37 Cr | 0.00 Cr | 0.00 Cr | 51.95 Cr | 178.5136 Cr |
| 2024-03-31 | 7.20 Cr | 445.68 Cr | 154.46 Cr | 291.2179 Cr | 2.69 Cr | -4.51 Cr | 77.74 Cr | 49.24 Cr | 3.24 Cr | 0.00 Cr | 54.92 Cr | 152.6938 Cr |
| 2023-03-31 | 1.93 Cr | 404.98 Cr | 163.76 Cr | 241.2212 Cr | 0.91 Cr | -1.02 Cr | 72.64 Cr | 52.68 Cr | 3.13 Cr | 0.00 Cr | 39.68 Cr | 161.3352 Cr |
| 2022-03-31 | 3.80 Cr | 347.17 Cr | 133.40 Cr | 213.7728 Cr | 4.22 Cr | 0.43 Cr | 79.99 Cr | 61.34 Cr | 1.41 Cr | 0.00 Cr | 24.76 Cr | 130.9058 Cr |
| 2021-03-31 | 2.20 Cr | 332.64 Cr | 142.00 Cr | 190.6435 Cr | 13.68 Cr | 11.48 Cr | 81.55 Cr | 71.18 Cr | 0.66 Cr | 0.00 Cr | 20.87 Cr | 139.4693 Cr |
Annual Financials Cash Flow Statement
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 37.1248 Cr | -19.9094 Cr | -4.8597 Cr | 16.9790 Cr | 12.3557 Cr | 19.5574 Cr | -20.1458 Cr | 61.0053 Cr | 8.4847 Cr | -12.5222 Cr | 0.9193 Cr |
| 2024-03-31 | 13.8244 Cr | -0.2296 Cr | -8.3199 Cr | 8.8078 Cr | 5.2749 Cr | 7.2017 Cr | -5.0166 Cr | 60.0575 Cr | 2.0134 Cr | -10.0254 Cr | -2.7639 Cr |
| 2023-03-31 | 53.9016 Cr | -43.4837 Cr | -12.2869 Cr | 52.3515 Cr | -1.8690 Cr | 1.9268 Cr | -1.5501 Cr | 47.4704 Cr | -3.1110 Cr | -8.7483 Cr | 7.2870 Cr |
| 2022-03-31 | 28.8637 Cr | -7.8171 Cr | -19.4492 Cr | 27.2489 Cr | 1.5974 Cr | 3.7958 Cr | -1.6148 Cr | 39.1220 Cr | -10.4867 Cr | -7.5577 Cr | 1.5025 Cr |
| 2021-03-31 | -18.7347 Cr | 52.2029 Cr | -33.1150 Cr | -24.8885 Cr | 0.3532 Cr | 2.1984 Cr | -6.1538 Cr | 38.5514 Cr | -30.9623 Cr | 0.0000 Cr | -19.9383 Cr |
Quarterly Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 198.14 Cr | 148.46 Cr | 49.68 Cr | 0.2507 | 15.91 Cr | 12.46 Cr | 2.49 | 20.07 Cr | 0.0629 |
| 2024-12-31 | 159.51 Cr | 120.48 Cr | 39.04 Cr | 0.2447 | 12.61 Cr | 10.34 Cr | 2.06 | 15.73 Cr | 0.0648 |
| 2024-09-30 | 165.95 Cr | 125.23 Cr | 40.72 Cr | 0.2454 | 14.96 Cr | 15.04 Cr | 3.00 | 20.28 Cr | 0.0906 |
| 2024-06-30 | 137.91 Cr | 112.22 Cr | 25.69 Cr | 0.1863 | 8.69 Cr | 9.51 Cr | 1.90 | 14.29 Cr | 0.0690 |
| 2024-03-31 | 163.89 Cr | 127.82 Cr | 36.07 Cr | 0.2201 | 17.00 Cr | 15.36 Cr | 3.06 | 22.05 Cr | 0.0937 |
Quarterly Financials Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 19.56 Cr | 54.32 Cr | 73.88 Cr | 216.41 Cr | 74.48 Cr | 376.17 Cr | 58.37 Cr | 506.63 Cr | 180.60 Cr |
| 2024-12-31 | 0.00 Cr | 0.00 Cr | 51.92 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -303.11 Cr |
| 2024-09-30 | 2.97 Cr | 49.27 Cr | 52.24 Cr | 184.10 Cr | 71.10 Cr | 314.44 Cr | 47.63 Cr | 434.19 Cr | 131.08 Cr |
| 2024-06-30 | 0.00 Cr | 0.00 Cr | 62.26 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -291.22 Cr |
| 2024-03-31 | 7.20 Cr | 55.05 Cr | 62.26 Cr | 193.13 Cr | 77.74 Cr | 336.20 Cr | 49.24 Cr | 445.68 Cr | 154.46 Cr |
Quarterly Financials Cash Flow Statement
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 12.46 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-12-31 | 10.34 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-09-30 | 15.04 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-06-30 | 9.51 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-03-31 | 15.36 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
Splits History
| Date | Label | Split Ratio |
|---|---|---|
| 2020-09-18 | September 18, 20 | 2:1 |
| 2015-08-05 | August 05, 15 | 3:1 |
| 2010-10-28 | October 28, 10 | 3:1 |
Similar Stocks: Medical - Pharmaceuticals
| Company Name | Symbol | Price | Market Cap | Volume |
|---|---|---|---|---|
| MedPlus Health Services Limited | MEDPLUS | ₹927.10 | ₹111,014,124,682.00 | ₹165,445.00 |
Key Executives
Gender: male
Year Born: 1981
Gender: male
Year Born: 1986
Gender: male
Year Born: 1949
Gender: male
Year Born:
Gender: male
Year Born:
Gender: male
Year Born:
Gender: male
Year Born: 1964
FAQs about Anuh Pharma Limited
The CEO is Ritesh Bipin Shah MBA.
The current price is ₹215.45.
The range is ₹148.05-241.35.
The market capitalization is ₹1,079.66 crores.
The dividend yield is 1.16%.
The P/E ratio is 22.80.
The company operates in the Healthcare sector.
Overview of Anuh Pharma Limited (ISIN: INE489G01022) is a leading Medical - Pharmaceuticals in India. With a market capitalization of ₹1,079.66 crores and an average daily volume of 13,779 shares, it operates in the Medical - Pharmaceuticals. The company last declared a dividend of ₹2.5.